XNCR Q3 2021 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M-44.3% YoY

Gross Profit

-$31M-157.1% margin

Operating Income

-$41M-209.8% margin

Net Income

-$40M-204.2% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

-70.8%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$43M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$697M

Total Liabilities

$78M

Stockholders' Equity

$619M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$35M	-44.3%
Gross Profit	-$31M	-$9M	-240.4%
Operating Income	-$41M	-$17M	-147.0%
Net Income	-$40M	-$13M	-220.2%

Revenue Segments

Royalty

$13M68%

Research collaboration

$6M32%